Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease
This study has been completed.
Study NCT00095810 Information provided by Bristol-Myers Squibb
First Received on November 9, 2004. Last Updated on December 2, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Parkinson's Disease
Psychoses
Additional conditions recognized in this trial
Mental Disorders
Parkinson Disease
Psychotic Disorders
More general conditions related to this trial
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Movement Disorders
Nervous System Diseases
Neurodegenerative Diseases
Parkinsonian Disorders
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
aripiprazole
More general drug interventions related to this trial
Antipsychotic Agents
Central Nervous System Agents
Central Nervous System Depressants
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Bristol-Myers Squibb
Otsuka America Pharmaceutical
Back to top of Main Content
